Abstract

The National Institute of Health (NIH) Library of integrated network-based cellular signatures (LINCS) program is premised on the generation of a publicly available data resource of cell-based biochemical responses or “signatures” to genetic or environmental perturbations. NeuroLINCS uses human inducible pluripotent stem cells (hiPSCs), derived from patients and healthy controls, and differentiated into motor neuron cell cultures. This multi-laboratory effort strives to establish i) robust multi-omic workflows for hiPSC and differentiated neuronal cultures, ii) public annotated data sets and iii) relevant and targetable biological pathways of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Here, we focus on the proteomics and the quality of the developed workflow of hiPSC lines from 6 individuals, though epigenomics and transcriptomics data are also publicly available. Known and commonly used markers representing 73 proteins were reproducibly quantified with consistent expression levels across all hiPSC lines. Data quality assessments, data levels and metadata of all 6 genetically diverse human iPSCs analysed by DIA-MS are parsable and available as a high-quality resource to the public. 

Measurement(s)

Protein expression

Technology Type(s)

Mass Spectrometry

Factor Type(s)

genetically distinct human cell lines

Sample Characteristic - Organism

Homo sapiens

Sample Characteristic - Location

United States

Details

Title
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency
Author
Matlock, Andrea D. 1   VIAFID ORCID Logo  ; Vaibhav, Vineet 1 ; Holewinski, Ronald 1 ; Venkatraman, Vidya 1 ; Dardov, Victoria 1 ; Manalo, Danica-Mae 1 ; Shelley, Brandon 2 ; Ornelas, Loren 2 ; Banuelos, Maria 2 ; Mandefro, Berhan 2 ; Escalante-Chong, Renan 3 ; Li, Jonathan 3 ; Finkbeiner, Steve 4   VIAFID ORCID Logo  ; Fraenkel, Ernest 3   VIAFID ORCID Logo  ; Rothstein, Jeffrey 5   VIAFID ORCID Logo  ; Thompson, Leslie 6   VIAFID ORCID Logo  ; Sareen, Dhruv 2   VIAFID ORCID Logo  ; Svendsen, Clive N. 2   VIAFID ORCID Logo  ; Van Eyk, Jennifer E. 1 ; Ho, Ritchie 2 ; Wassie, Brook 3 ; Patel-Murray, Natasha 3 ; Milani, Pamela 3 ; Adam, Miriam 3 ; Sachs, Karen 3 ; Lenail, Alex 3 ; Ramamoorthy, Divya 3 ; Daigle, Gavin 3 ; Hussain, Uzma 3 ; Kaye, Julia 4 ; Lima, Leandro 4 ; Kalra, Jaslin 4 ; Coyne, Alyssa 5 ; Lim, Ryan G 6 ; Wu, Jie 6 ; Stocksdale, Jennifer 6 ; Thompson, Terri G 6 

 Cedars-Sinai Medical Center, NeuroLINCS, Advanced Clinical Biosystems Research Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 Cedars-Sinai Medical Center, NeuroLINCS, Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 NeuroLINCS, Department of Biological Engineering, MIT, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786) 
 University of California San Francisco, NeuroLINCS, Gladstone Institute of Neurological Disease and the Departments of Neurology and Physiology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Johns Hopkins University, NeuroLINCS, Department of Neuroscience, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 University of California Irvine, NeuroLINCS, Departments of Psychiatry and Human Behaviour, Neurobiology and Behaviour and UCI MIND, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243) 
Pages
24
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20524463
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2764040205
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.